Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(3.22)
# 1,074
Out of 4,761 analysts
187
Total ratings
27.98%
Success rate
8.19%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.58 | +1,099.86% | 8 | Feb 19, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $12 → $15 | $3.54 | +323.73% | 5 | Dec 20, 2024 | |
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.20 | +650.00% | 7 | Dec 18, 2024 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 → $19 | $11.63 | +63.37% | 5 | Dec 18, 2024 | |
| NVAX Novavax | Reiterates: Buy | $19 | $7.99 | +137.80% | 22 | Dec 10, 2024 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $1.16 | +331.03% | 10 | Dec 9, 2024 | |
| WINT Windtree Therapeutics | Reiterates: Neutral | $7 | $4.35 | +60.92% | 2 | Dec 4, 2024 | |
| SAVA Cassava Sciences | Downgrades: Neutral | $116 | $2.55 | +4,449.02% | 22 | Nov 26, 2024 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.28 | +733.33% | 5 | Nov 25, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $16 | $4.29 | +272.96% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.67 | +379.04% | 14 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.96 | +108.09% | 8 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.47 | +308.16% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.80 | +5,455.56% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.80 | +900.00% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $2.43 | +764.20% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $1.67 | +2,055.69% | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.36 | +10,929.41% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $1.28 | +3,415.63% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.35 | +1,381.48% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.33 | +363,666.54% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.80 | +3,011.39% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $20.20 | +1,088.12% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.10 | +7,205.27% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.45 | +6,796.55% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.75 | +118,418.52% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $2.57 | +172.37% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $3.19 | +840.44% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.17 | +1,161.83% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.40 | +4,445.45% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.49 | +235.57% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $5.07 | +28,302.37% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $50.26 | -52.25% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $2.70 | +126,421.40% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $4.76 | +399,059.66% | 1 | Oct 6, 2017 |
Aethlon Medical
Feb 19, 2025
Reiterates: Buy
Price Target: $7
Current: $0.58
Upside: +1,099.86%
Humacyte
Dec 20, 2024
Reiterates: Buy
Price Target: $12 → $15
Current: $3.54
Upside: +323.73%
Cardiol Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $9
Current: $1.20
Upside: +650.00%
Candel Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $11 → $19
Current: $11.63
Upside: +63.37%
Novavax
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.99
Upside: +137.80%
Artelo Biosciences
Dec 9, 2024
Reiterates: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
Windtree Therapeutics
Dec 4, 2024
Reiterates: Neutral
Price Target: $7
Current: $4.35
Upside: +60.92%
Cassava Sciences
Nov 26, 2024
Downgrades: Neutral
Price Target: $116
Current: $2.55
Upside: +4,449.02%
NRx Pharmaceuticals
Nov 25, 2024
Reiterates: Buy
Price Target: $19
Current: $2.28
Upside: +733.33%
Eledon Pharmaceuticals
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $4.29
Upside: +272.96%
Nov 20, 2024
Reiterates: Buy
Price Target: $8
Current: $1.67
Upside: +379.04%
Nov 15, 2024
Reiterates: Buy
Price Target: $2
Current: $0.96
Upside: +108.09%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.47
Upside: +308.16%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.80
Upside: +5,455.56%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.80
Upside: +900.00%
Aug 20, 2024
Reiterates: Buy
Price Target: $21
Current: $2.43
Upside: +764.20%
May 14, 2024
Reiterates: Buy
Price Target: $36
Current: $1.67
Upside: +2,055.69%
Jan 30, 2024
Initiates: Buy
Price Target: $150
Current: $1.36
Upside: +10,929.41%
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $1.28
Upside: +3,415.63%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.35
Upside: +1,381.48%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.33
Upside: +363,666.54%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.80
Upside: +3,011.39%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $20.20
Upside: +1,088.12%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.10
Upside: +7,205.27%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.45
Upside: +6,796.55%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.75
Upside: +118,418.52%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $2.57
Upside: +172.37%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $3.19
Upside: +840.44%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.17
Upside: +1,161.83%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.40
Upside: +4,445.45%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.49
Upside: +235.57%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $5.07
Upside: +28,302.37%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $50.26
Upside: -52.25%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $2.70
Upside: +126,421.40%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $4.76
Upside: +399,059.66%